Skip to main content

How Does Diversity Affect Innovation in Pharma?

Event Dates
September 14, 2022, All day

Studies suggest that a diverse and inclusive workforce augments innovation throughout the pharmaceutical industry. A panel of four leaders discussed their perspectives on these data and how diversity has impacted discoveries within their field. Their formal remarks were followed by an open discussion of questions submitted by seminar registrants and attendees.

Presentation Materials and Video Recording

Dr. Bernard headshot

Marie A. Bernard, M.D.

Marie A. Bernard, M.D., Chief Officer for Scientific Workforce Diversity (COSWD), NIH


Aida Habtezion, M.D., MSc, FRCPC, AGAF

Aida Habtezion, M.D., MSc, FRCPC, AGAF, Chief Medical Officer and Head of Worldwide Medical & Safety, Pfizer


Graham Jones, Ph.D., D.Sc.

Graham Jones, Ph.D., D.Sc., Head of Connected Health Research and Innovation, Novartis


Michelle McMurry-Heath, M.D., Ph.D.

Michelle McMurry-Heath, M.D., Ph.D., President and CEO, Biotechnology Innovation Organization


Meena Subramanyam, Ph.D.

 Meena Subramanyam, Ph.D., Global Program Leader and Conditional T cell Engager Platform Lead, Takeda Oncology


Faith Harrow Plante, Ph.D.

Faith Harrow Plante, Ph.D., Chair of the NIH Training Directors Committee, Scientific Training Director, National Human Genome Research Institute, NIH


Sharon Milgram, Ph.D

Sharon Milgram, Ph.D., Director of the Office of Intramural Training & Education, NIH